Form 4: Lemaitre Vascular Director Ross Acquires Dividend Equivalent Rights

Director Bridget A. Ross acquired dividend equivalent rights related to restricted stock unit and performance share unit awards.

Summary

• On August 29, 2024, Bridget A. Ross, a director of Lemaitre Vascular Inc. (LMAT), acquired dividend equivalent rights.
• These rights are associated with previously granted restricted stock unit (RSU) and performance share unit (PSU) awards.
• The dividend equivalent rights vest proportionately with the underlying awards.
• Ross acquired 0.358 rights related to an RSU award from December 11, 2021, 0.7254 rights related to an RSU award from December 12, 2022, 0.7254 rights related to a PSU award from December 12, 2022, and 0.9285 rights related to an RSU award from December 8, 2023.
• Each dividend equivalent right represents the economic equivalent of one share of Lemaitre Vascular's common stock.
• Following the transaction, Ross directly owns 7.6743, 7.4911, 6.5024, and 3.2056 dividend equivalent rights respectively.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing, and the acquisition of dividend equivalent rights is a neutral event.

Positives

• The acquisition of dividend equivalent rights suggests continued alignment of the director's interests with those of the shareholders.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders and their alignment with shareholder interests.

Stakeholder Impact

• The acquisition of dividend equivalent rights aligns the director's interests with those of the shareholders, as the value of these rights is tied to the performance of the company's stock.

Key Dates